$17.3MSeries B, 22 October 2025
Funds clinical and regulatory operations and first-in-human trials on the ALTA platform.
- Amount
- $17.3M
- Stage
- Series B
- Announced
- 22 October 2025
- Lead
- Adjuvant Capital
- Other investors
- RA Capital Management
- Use of funds
- Funds clinical and regulatory operations and first-in-human trials on the ALTA platform.
- Checked
- Announced by the company
- Sources
- VitriVax raises $17.25M in Series B funding round - BizWest businesswire.com
VitriVax raises $17.25M in Series B funding round - BizWest BizWest
VitriVax raises $17.25M in Series B funding round - BizWest pulse.bot